Special Issue "Natural Toxins/Molecules (and Derivatives) from Animal Venoms: from Basic Research to Therapeutic Applications 2019"
Deadline for manuscript submissions: closed (30 September 2019) | Viewed by 29287
Interests: antimicrobial peptides; antibacterial; antibiotics; structure-activity relationships; bacteriocins; drug design; peptide engineering
Special Issues, Collections and Topics in MDPI journals
Special Issue in Toxins: Toxins - Organic and Analytical Chemistry
Special Issue in Toxins: Animal Venoms
Special Issue in Toxins: Ion Channel Neurotoxins
Special Issue in Molecules: Structure-Activity Relationship of Natural Products
Special Issue in Molecules: Natural Toxins/Molecules (and Derivatives) from Animal Venoms: From Basic Research to Therapeutic Applications
Special Issue in Marine Drugs: Ion Channels as Marine Drug Targets
Special Issue in Antibiotics: Antibacterial Peptides
Special Issue in Antibiotics: Peptide Antibiotics from Microbes and Venomous Animals
Special Issue in Marine Drugs: Ion Channels as Marine Drug Targets 2021
Special Issue in Sci: Natural Extracts and Bioactive Derivatives: Strategies for Biopharmaceutical Uses
Special Issue in Antibiotics: 10th Anniversary of Antibiotics–Recent Advances in Antimicrobial Peptides
Special Issue in Molecules: Medicinal Chemistry in Europe III
Special Issue in Molecules: Bioactive Molecules in SARS-CoV-2 Infection and Covid-19
Special Issue in Antibiotics: Reviews on Antimicrobial Peptides
Special Issue in Molecules: Medicinal Chemistry in Europe IV
Venomous animals (e.g., scorpions, snakes, sea anemones, cone snails, worms, wasps and frogs) are invaluable natural sources of biologically-active compounds that target a variety of receptors/molecules (ion channels, enzymes, etc.). These compounds are generally highly potent, but can display variable selectivities. Interestingly, a number of molecules from venoms reportedly possess some therapeutic potential to treat pain, microbial infections, and more or less severe pathologies such as cancer, autoimmune and neurological diseases. This special issue of Molecules is devoted to the many aspects of marine and non-marine toxins/molecules (and derivatives thereof) from animal venoms, including their pharmacological properties, structural characteristics, structure-function relationship, molecular engineering/drug design, and therapeutic value. All scientists and clinicians working in these emerging and promising fields of research are strongly encouraged to submit their original works for publication in this Special Issue.Dr. Jean-Marc Sabatier
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- animal toxin
- venomous animal
- toxin engineering
- drug design
- chemotherapeutic drug
- ion channel
- autoimmune disease
- neurological disorder